Industry

OCT-A detects glaucoma progression earliest in study

Healio Optometry5d ago1 min read

OCT angiography may help detect glaucoma progression earlier than standard OCT or visual field exams, although its specificity was lower than that of structural OCT, according to data published in JAMA Ophthalmology.“Glaucoma progression is commonly monitored with structural OCT and visual field testing, but these tests do not always show progression at the same time,” Takashi Nishida, MD, PhD, associate project scientist at the Shiley Eye Institute, told Healio. “We conducted this study to compare when progression is detected by OCT-A, structural OCT and visual field

Read full article on Healio Optometry

AI Summary

Quick Take

A study published in JAMA Ophthalmology found that OCT angiography (OCT-A) may detect glaucoma progression earlier than traditional structural OCT or visual field exams. While OCT-A demonstrated higher sensitivity for early detection, researchers noted that its specificity was lower than that of standard structural OCT.

Why It Matters

Clinicians often struggle with the 'diagnostic gap' in glaucoma management, where structural damage and functional loss do not always progress at the same rate. By identifying microvascular changes that may precede other markers, OCT-A could provide a more proactive window for intervention. However, the trade-off in specificity suggests that while OCT-A is a powerful early-warning tool, it should currently be used to complement, rather than replace, established structural and functional testing.

Key Findings

OCT-A identified glaucoma progression earlier than both standard structural OCT and visual field testing.
The specificity of OCT-A for detecting progression was found to be lower than that of structural OCT.
The study highlights that microvascular changes captured by OCT-A may serve as an earlier indicator of disease advancement than traditional metrics.

Study Snapshot

Design

Comparative longitudinal study

Population

Patients monitored for glaucoma progression

Practice Implications

Eye care providers should consider OCT-A as a supplemental tool for high-risk patients who appear stable on visual fields and structural OCT. Given the lower specificity, clinicians should look for corroborating evidence across multiple testing modalities before significantly escalating treatment based on OCT-A changes alone.

Who's Affected

Glaucoma SpecialistsComprehensive OphthalmologistsOptometrists

Evidence StrengthModerate

AI-generated summary — always read the original source for full context

Discussion

No comments yet. Be the first to share your thoughts.